This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by vom Dahl, J. Articles by Schwaiger, M. Search for Related Content PubMed PubMed Citation Articles by vom Dahl, J. Articles by Schwaiger, M.

(Circulation. 1996;93:238-245.)
© 1996 American Heart Association, Inc.

Articles

Myocardial Rubidium-82 Tissue Kinetics Assessed by Dynamic Positron Emission Tomography as a Marker of Myocardial Cell Membrane Integrity and Viability

Juergen vom Dahl, MD; Otto Muzik, PhD; Edwin R. Wolfe, Jr, MS; Christine Allman, CNMT; Gary Hutchins, PhD; Markus Schwaiger, MD, FACC

From the Division of Nuclear Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor.

Correspondence to Juergen vom Dahl, MD, Medizinische Klinik I der RWTH Aachen, Klinikum Aachen, Pauwelsstr 30, 52057 Aachen, FRG.

Background Recent reports have demonstrated the clinical use of rubidium-82 chloride (Rb-82) in combination with positron emission tomography (PET) not only as a tracer of myocardial blood flow but also as a marker of cell membrane integrity using static imaging early and late after tracer injection. The purpose of this study was to compare myocardial Rb-82 kinetics assessed by dynamic PET imaging as a marker for tissue viability with regional fluorine-18 fluorodeoxyglucose (FDG) uptake in patients with coronary artery disease.

Methods and Results Twenty-seven patients with angiographically proven coronary artery disease and 5 subjects with a low likelihood for coronary artery disease underwent dynamic PET imaging under resting conditions using Rb-82 and FDG. Both image sequences served as input data for a semiautomated regional analysis program. This program generated polar maps representing Rb-82 tissue half-life and FDG utilization assessed by Patlak's approach. Myocardial tissue viability was visually determined from static Rb-82 and FDG images. Regions were categorized as normal, ischemically compromised, and scar tissue. Their coordinates were subsequently copied to the functional polar maps for further analyses. In normal subjects, Rb-82 tissue half-life was homogeneous throughout the left ventricle (90±11 seconds). In coronary patients, differences between Rb-82 tissue half-lives in normal and scar tissue were highly significant (95±10 and 57±15 seconds, respectively; P<.0001). FDG uptake in these two tissue groups was 78±12% and 40±13%, respectively (P<.0001). Ischemically compromised tissue with reduced perfusion but maintained FDG uptake displayed an Rb-82 half-life of 75±9 seconds, indicating active cellular tracer retention, which was significantly different from scar tissue. Overall agreement of tissue categorization as either viable or scar was 86% between Rb-82 kinetics and FDG utilization. In a subgroup of 11 patients with all three tissue types within one image set, Rb-82 tissue half-life discriminated between normal, ischemic, and scar tissue (97±9, 75±9, and 60±15 seconds, respectively; P<.01).

Conclusions This study demonstrated a significant relationship between cell membrane integrity as assessed by dynamic Rb-82 PET imaging and myocardial glucose utilization as a marker for tissue viability. In regions with reduced perfusion, Rb-82 kinetics was different in compromised but metabolically active and irreversibly injured myocardium. The predictive value of this approach must be evaluated in follow-up studies.

Key Words: tomography • potassium • perfusion • myocardium

This article has been cited by other articles:

				M. A. Stankewicz, C. S. Mansour, R. L. Eisner, K. B. Churchwell, B. R. Williams, S. R. Sigman, J. Streeter, and R. E. Patterson Myocardial Viability Assessment by PET: 82Rb Defect Washout Does Not Predict the Results of Metabolic-Perfusion Mismatch J. Nucl. Med., October 1, 2005; 46(10): 1602 - 1609. [Abstract] [Full Text] [PDF]

				M. Schwaiger, S. Ziegler, and S. G. Nekolla PET/CT: Challenge for Nuclear Cardiology J. Nucl. Med., October 1, 2005; 46(10): 1664 - 1678. [Abstract] [Full Text] [PDF]

				G. El Fakhri, A. Sitek, B. Guerin, M. F. Kijewski, M. F. Di Carli, and S. C. Moore Quantitative Dynamic Cardiac 82Rb PET Using Generalized Factor and Compartment Analyses J. Nucl. Med., August 1, 2005; 46(8): 1264 - 1271. [Abstract] [Full Text] [PDF]

				S.R. Underwood, J. J Bax, J. v. Dahl, M. Y Henein, A. C van Rossum, E. R Schwarz, J.-L. Vanoverschelde, E. E.v. d. Wall, and W. Wijns Imaging techniques for the assessment of myocardial hibernation: Report of a Study Group of the European Society of Cardiology Eur. Heart J., May 2, 2004; 25(10): 815 - 836. [Abstract] [Full Text] [PDF]